{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:35:09Z","timestamp":1776983709298,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","award":["795389"],"award-info":[{"award-number":["795389"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>End-stage liver diseases (ESLDs) are a significant global health challenge due to their high prevalence and severe health impacts. Despite the severe outcomes associated with ESLDs, therapeutic options remain limited. Targeting the activation of hepatic stellate cells (HSCs), key drivers of extracellular matrix accumulation during liver injury presents a novel therapeutic approach. In ESLDs patients, branched-chain amino acids (BCAAs, leucine, isoleucine and valine) levels are decreased, and supplementation has been proposed to attenuate liver fibrosis and improve regeneration. However, their effects on HSCs require further investigation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To evaluate the efficacy of BCAAs and their metabolites, branched-chain \u03b1-keto acids (BCKAs), in modulating HSCs activation in human and rat models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Primary HSCs from rats and cirrhotic and non-cirrhotic human livers, were cultured and treated with BCAAs or BCKAs to assess their effects on both preventing (from day 1 of isolation) and reversing (from day 7 of isolation) HSCs activation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In rat HSCs, leucine and BCKAs significantly reduced fibrotic markers and cell proliferation. In human HSCs, the metabolite of isoleucine decreased cell proliferation around 85% and increased the expression of branched-chain ketoacid dehydrogenase. The other metabolites also showed antifibrotic effects in HSCs from non-cirrhotic human livers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>BCAAs and their respective metabolites inhibit HSC activation with species-specific responses. Further research is needed to understand how BCAAs influence liver fibrogenesis. BCKAs supplementation could be a strategic approach for managing ESLDs, considering the nutritional status and amino acid profiles of patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n            <jats:p>The antifibrotic effects of BCAAs and BCKAs in various conditions are depicted for human HSCs (left) and rat HSCs (right) The symbol \u2018\u2193\u2019 indicates a downregulation or a decrease. <jats:italic>\u03b1-SMA<\/jats:italic> alpha-smooth muscle actin, <jats:italic>BCAAs<\/jats:italic> branched-chain amino acids, <jats:italic>BCKAs<\/jats:italic> branched-chain keto acids, <jats:italic>HSCs<\/jats:italic> hepatic stellate cells, <jats:italic>KMV<\/jats:italic> \u03b1-keto-\u03b2-methylvalerate. Figure created with Biorender.com<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11033-024-10027-4","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T07:07:57Z","timestamp":1730704077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Branched-chain amino acids and their metabolites decrease human and rat hepatic stellate cell activation"],"prefix":"10.1007","volume":"51","author":[{"given":"Maria Camila","family":"Trillos-Almanza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnolia Martinez","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon","family":"Buist-Homan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Bomer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla Arevalo","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent E.","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederike G. I.","family":"van Vilsteren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Blokzijl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Moshage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"key":"10027_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/S41575-023-00759-2","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, Loomba R (2023) Global epidemiology of cirrhosis\u2014aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol 20:388\u2013398. https:\/\/doi.org\/10.1038\/S41575-023-00759-2","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10027_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/S13287-022-03001-Z","author":"L Yao","year":"2022","unstructured":"Yao L, Hu X, Dai K, Yuan M, Liu P, Zhang Q, Jiang Y (2022) Mesenchymal stromal cells: promising treatment for liver cirrhosis. Stem Cell Res Ther. https:\/\/doi.org\/10.1186\/S13287-022-03001-Z","journal-title":"Stem Cell Res Ther"},{"key":"10027_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS (2021) Liver cirrhosis. Lancet 398:1359\u20131376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X","journal-title":"Lancet"},{"key":"10027_CR4","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/WJG.V22.I48.10512","volume":"22","author":"CY Zhang","year":"2016","unstructured":"Zhang CY, Yuan WG, He P, Lei JH, Wang CX (2016) Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol 22:10512. https:\/\/doi.org\/10.3748\/WJG.V22.I48.10512","journal-title":"World J Gastroenterol"},{"key":"10027_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS23074022","author":"A Dimou","year":"2022","unstructured":"Dimou A, Tsimihodimos V, Bairaktari E (2022) The critical role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain \u03b1-Keto Acid Dehydrogenase (BCKD), in human pathophysiology. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS23074022","journal-title":"Int J Mol Sci"},{"key":"10027_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/S12986-018-0271-1","author":"M Hole\u010dek","year":"2018","unstructured":"Hole\u010dek M (2018) Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements. Nutr Metab (Lond). https:\/\/doi.org\/10.1186\/S12986-018-0271-1","journal-title":"Nutr Metab (Lond)"},{"key":"10027_CR7","doi-asserted-by":"publisher","first-page":"106604","DOI":"10.1016\/J.PHRS.2022.106604","volume":"187","author":"T Wu","year":"2023","unstructured":"Wu T, Wang M, Ning F, Zhou S, Hu X, Xin H, Reilly S, Zhang X (2023) Emerging role for branched-chain amino acids metabolism in fibrosis. Pharmacol Res 187:106604. https:\/\/doi.org\/10.1016\/J.PHRS.2022.106604","journal-title":"Pharmacol Res"},{"key":"10027_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.21037\/TGH.2018.07.06","volume":"3","author":"K Tajiri","year":"2018","unstructured":"Tajiri K, Shimizu Y (2018) Branched-chain amino acids in liver diseases. Transl Gastroenterol Hepatol 3:47. https:\/\/doi.org\/10.21037\/TGH.2018.07.06","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10027_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0159205","author":"B Kinny-K\u00f6ster","year":"2016","unstructured":"Kinny-K\u00f6ster B, Bartels M, Becker S, Scholz M, Thiery J, Ceglarek U, Kaiser T (2016) Plasma amino acid concentrations predict mortality in patients with end-stage liver disease. PLoS ONE. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0159205","journal-title":"PLoS ONE"},{"key":"10027_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/J.CLNU.2022.03.027","volume":"41","author":"G Konstantis","year":"2022","unstructured":"Konstantis G, Pourzitaki C, Chourdakis M, Kitsikidou E, Germanidis G (2022) Efficacy of branched chain amino acids supplementation in liver cirrhosis: a systematic review and meta-analysis. Clin Nutr 41:1171\u20131190. https:\/\/doi.org\/10.1016\/J.CLNU.2022.03.027","journal-title":"Clin Nutr"},{"key":"10027_CR11","doi-asserted-by":"publisher","first-page":"e00542","DOI":"10.14309\/CTG.0000000000000542","volume":"13","author":"H Lee","year":"2022","unstructured":"Lee H, Yoo JJ, Ahn SH, Kim BK (2022) New evidence of oral branched-chain amino acid supplementation on the prognosis of patients with advanced liver disease. Clin Transl Gastroenterol 13:e00542. https:\/\/doi.org\/10.14309\/CTG.0000000000000542","journal-title":"Clin Transl Gastroenterol"},{"key":"10027_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/FCP.12297","volume":"31","author":"NF Khedr","year":"2017","unstructured":"Khedr NF, Khedr EG (2017) Branched chain amino acids supplementation modulates TGF-\u03b21\/Smad signaling pathway and interleukins in CCl4-induced liver fibrosis. Fundam Clin Pharmacol 31:534\u2013545. https:\/\/doi.org\/10.1111\/FCP.12297","journal-title":"Fundam Clin Pharmacol"},{"key":"10027_CR13","doi-asserted-by":"publisher","first-page":"18191","DOI":"10.18632\/ONCOTARGET.15304","volume":"8","author":"K Takegoshi","year":"2017","unstructured":"Takegoshi K, Honda M, Okada H, Takabatake R, Matsuzawa-Nagata N, Campbell JS, Nishikawa M, Shimakami T, Shirasaki T, Sakai Y, Yamashita T, Takamura T, Tanaka T, Kaneko S (2017) Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model. Oncotarget 8:18191\u201318205. https:\/\/doi.org\/10.18632\/ONCOTARGET.15304","journal-title":"Oncotarget"},{"key":"10027_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3904\/KJIM.2020.197","volume":"37","author":"HL Lee","year":"2022","unstructured":"Lee HL, Lee J, Cha JH, Cho S, Sung PS, Hur W, Yoon SK, Bae SH (2022) Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells. Korean J Intern Med 37:53. https:\/\/doi.org\/10.3904\/KJIM.2020.197","journal-title":"Korean J Intern Med"},{"key":"10027_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PBIO.3000410","author":"NP du Sert","year":"2020","unstructured":"du Sert NP, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, W\u00fcrbel H (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. https:\/\/doi.org\/10.1371\/JOURNAL.PBIO.3000410","journal-title":"PLoS Biol"},{"key":"10027_CR16","doi-asserted-by":"publisher","unstructured":"(2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194. https:\/\/doi.org\/10.1001\/JAMA.2013.281053","DOI":"10.1001\/JAMA.2013.281053"},{"key":"10027_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRS.2020.104720","author":"X Cai","year":"2020","unstructured":"Cai X, Wang J, Wang J, Zhou Q, Yang B, He Q, Weng Q (2020) Intercellular crosstalk of hepatic stellate cells in liver fibrosis: new insights into therapy. Pharmacol Res. https:\/\/doi.org\/10.1016\/J.PHRS.2020.104720","journal-title":"Pharmacol Res"},{"key":"10027_CR18","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/HEP.32776","volume":"77","author":"J Knorr","year":"2023","unstructured":"Knorr J, Kaufmann B, Inzaugarat ME, Holtmann TM, Geisler L, Hundertmark J, Kohlhepp MS, Boosheri LM, Chilin-Fuentes DR, Birmingham A, Fisch KM, Schilling JD, Loosen SH, Trautwein C, Roderburg C, Demir M, Tacke F, Hoffman HM, Feldstein AE, Wree A (2023) Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Hepatology 77:1968. https:\/\/doi.org\/10.1002\/HEP.32776","journal-title":"Hepatology"},{"key":"10027_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/J.CLNU.2018.12.022","volume":"38","author":"M Plauth","year":"2019","unstructured":"Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Sch\u00fctz T, Bischoff SC (2019) ESPEN guideline on clinical nutrition in liver disease. Clin Nutr 38:485\u2013521. https:\/\/doi.org\/10.1016\/J.CLNU.2018.12.022","journal-title":"Clin Nutr"},{"key":"10027_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/J.JHEP.2018.06.024","volume":"70","author":"M Merli","year":"2019","unstructured":"Merli M, Berzigotti A, Zelber-Sagi S, Dasarathy S, Montagnese S, Genton L, Plauth M, Par\u00e9s A (2019) EASL clinical practice guidelines on nutrition in chronic liver disease. J Hepatol 70:172\u2013193. https:\/\/doi.org\/10.1016\/J.JHEP.2018.06.024","journal-title":"J Hepatol"},{"key":"10027_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/J.CLNESP.2018.07.012","volume":"28","author":"PH Ooi","year":"2018","unstructured":"Ooi PH, Gilmour SM, Yap J, Mager DR (2018) Effects of branched chain amino acid supplementation on patient care outcomes in adults and children with liver cirrhosis: a systematic review. Clin Nutr ESPEN 28:41\u201351. https:\/\/doi.org\/10.1016\/J.CLNESP.2018.07.012","journal-title":"Clin Nutr ESPEN"},{"key":"10027_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MD.0000000000006580","volume":"96","author":"JG Park","year":"2017","unstructured":"Park JG, Tak WY, Park SY, Kweon YO, Jang SY, Lee YR, Bae SH, Jang JY, Kim DY, Lee JS, Suk KT, Kim IH, Lee HJ, Chung WJ, Jang BK, Suh JI, Heo J, Lee WK (2017) Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: a Korean nationwide, multicenter, retrospective, observational, cohort study. Medicine 96:24. https:\/\/doi.org\/10.1097\/MD.0000000000006580","journal-title":"Medicine"},{"key":"10027_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/JOURNAL.PONE.0077899","volume":"8","author":"JH Cha","year":"2013","unstructured":"Cha JH, Bae SH, Kim HL, Park NR, Choi ES, Jung ES, Choi JY, Yoon SK (2013) Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis. PLoS ONE 8:1. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0077899","journal-title":"PLoS ONE"},{"key":"10027_CR24","doi-asserted-by":"publisher","first-page":"A73","DOI":"10.1136\/THORAXJNL-2014-206260.142","volume":"69","author":"HV Woodcock","year":"2014","unstructured":"Woodcock HV, Peace S, Nanthakumar CB, Maher TM, Mercer PF, Chambers RC, Barratt SL, Blythe T, Jarrett C, Welsh GI, Ourradi K, Scotton C, Bates DO, Millar AB (2014) S136 Mtor signalling is an essential pathway for Tgf-\u03b21 induced \u03b1sma and collagen gene expression. Thorax 69:A73\u2013A73. https:\/\/doi.org\/10.1136\/THORAXJNL-2014-206260.142","journal-title":"Thorax"},{"key":"10027_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1167\/IOVS.18-25376","volume":"60","author":"SW Kim","year":"2019","unstructured":"Kim SW, Kim HI, Thapa B, Nuwromegbe S, Lee K (2019) Critical role of mTORC2-Akt signaling in TGF-\u03b21-induced myofibroblast differentiation of human pterygium fibroblasts. Invest Ophthalmol Vis Sci 60:82\u201392. https:\/\/doi.org\/10.1167\/IOVS.18-25376","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10027_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/KI.2015.119","volume":"88","author":"J Li","year":"2015","unstructured":"Li J, Ren J, Liu X, Jiang L, He W, Yuan W, Yang J, Dai C (2015) Rictor\/mTORC2 signaling mediates TGF\u03b21-induced fibroblast activation and kidney fibrosis. Kidney Int 88:515\u2013527. https:\/\/doi.org\/10.1038\/KI.2015.119","journal-title":"Kidney Int"},{"key":"10027_CR27","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/J.BBAMCR.2007.07.005","volume":"1773","author":"MP P\u00e9rez de Obanos","year":"2007","unstructured":"P\u00e9rez de Obanos MP, L\u00f3pez-Zabalza MJ, Arriazu E, Modol T, Prieto J, Herraiz MT, Iraburu MJ (2007) Reactive oxygen species (ROS) mediate the effects of leucine on translation regulation and type I collagen production in hepatic stellate cells. Biochim Biophys Acta 1773:1681\u20131688. https:\/\/doi.org\/10.1016\/J.BBAMCR.2007.07.005","journal-title":"Biochim Biophys Acta"},{"key":"10027_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/JCP.20790","volume":"209","author":"MP P\u00e9rez De Obanos","year":"2006","unstructured":"P\u00e9rez De Obanos MP, L\u00f3pez Zabalza MJ, Prieto J, Herraiz MT, Iraburu MJ (2006) Leucine stimulates procollagen alpha1(I) translation on hepatic stellate cells through ERK and PI3K\/Akt\/mTOR activation. J Cell Physiol 209:580\u2013586. https:\/\/doi.org\/10.1002\/JCP.20790","journal-title":"J Cell Physiol"},{"key":"10027_CR29","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/S00726-011-0983-2\/FIGURES\/2","volume":"41","author":"F Li","year":"2011","unstructured":"Li F, Yin Y, Tan B, Kong X, Wu G (2011) Leucine nutrition in animals and humans: MTOR signaling and beyond. Amino Acids 41:1185\u20131193. https:\/\/doi.org\/10.1007\/S00726-011-0983-2\/FIGURES\/2","journal-title":"Amino Acids"},{"key":"10027_CR30","doi-asserted-by":"publisher","first-page":"11647","DOI":"10.1074\/JBC.274.17.11647","volume":"274","author":"SR Kimball","year":"1999","unstructured":"Kimball SR, Shantz LM, Horetsky RL, Jefferson LS (1999) Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J Biol Chem 274:11647\u201311652. https:\/\/doi.org\/10.1074\/JBC.274.17.11647","journal-title":"J Biol Chem"},{"key":"10027_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.12997\/JLA.2020.9.1.8","volume":"9","author":"HS Yeh","year":"2020","unstructured":"Yeh HS, Yong J (2020) mTOR-coordinated post-transcriptional gene regulations: from fundamental to pathogenic insights. J Lipid Atheroscler 9:8. https:\/\/doi.org\/10.12997\/JLA.2020.9.1.8","journal-title":"J Lipid Atheroscler"},{"key":"10027_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/AJCN\/68.1.72","volume":"68","author":"A Sitryawan","year":"1998","unstructured":"Sitryawan A, Hawes JW, Harris RA, Shimomura Y, Jenkins AE, Hutson SM (1998) A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 68:72\u201381. https:\/\/doi.org\/10.1093\/AJCN\/68.1.72","journal-title":"Am J Clin Nutr"},{"key":"10027_CR33","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1042\/BCJ20190182","volume":"476","author":"EJ Goldberg","year":"2019","unstructured":"Goldberg EJ, Buddo KA, McLaughlin KL, Fernandez RF, Pereyra AS, Psaltis CE, Te LC, Hagen JT, Boykov IN, Nguyen TK, Gowdy KM, Ellis JM, Neufer PD, McClung JM, Fisher-Wellman KH (2019) Tissue-specific characterization of mitochondrial branched-chain keto acid oxidation using a multiplexed assay platform. Biochem J 476:1521. https:\/\/doi.org\/10.1042\/BCJ20190182","journal-title":"Biochem J"},{"key":"10027_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/J.FREERADBIOMED.2021.08.240","volume":"175","author":"S Liu","year":"2021","unstructured":"Liu S, Li L, Lou P, Zhao M, Wang Y, Tang M, Gong M, Liao G, Yuan Y, Li L, Zhang J, Chen Y, Cheng J, Lu Y, Liu J (2021) Elevated branched-chain \u03b1-keto acids exacerbate macrophage oxidative stress and chronic inflammatory damage in type 2 diabetes mellitus. Free Radic Biol Med 175:141\u2013154. https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2021.08.240","journal-title":"Free Radic Biol Med"},{"key":"10027_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/S41387-022-00213-3","author":"F Vanweert","year":"2022","unstructured":"Vanweert F, Schrauwen P, Phielix E (2022) Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes. Nutr Diabetes. https:\/\/doi.org\/10.1038\/S41387-022-00213-3","journal-title":"Nutr Diabetes"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10027-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-10027-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10027-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:42:44Z","timestamp":1738730564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-10027-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10027"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-10027-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"All animal care practices adhered to the legal standards set by the guidelines of the Institutional Animal Care and Use Committee for Laboratory Animals at the University of Groningen. The experimental protocols received approval from the Animal Ethics Committee (IvD protocol AVD10500202115139) and were conducted according to the ARRIVE guidelines for animal research. All participants agreed to the informed consent. The human research was approved by the Medical Ethical Committee at the UMCG in accordance with Dutch laws and the guidelines stipulated in the Code of Conduct for responsibly handling human tissue in health research, and following the guidelines of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"1116"}}